KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aquestive Therapeutics (AQST) Change in Inventory (2017 - 2025)

Historic Change in Inventory for Aquestive Therapeutics (AQST) over the last 9 years, with Q3 2025 value amounting to -$241000.0.

  • Aquestive Therapeutics' Change in Inventory fell 53818.18% to -$241000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $863000.0, marking a year-over-year increase of 158793.1%. This contributed to the annual value of -$725000.0 for FY2024, which is 17330.64% down from last year.
  • Latest data reveals that Aquestive Therapeutics reported Change in Inventory of -$241000.0 as of Q3 2025, which was down 53818.18% from $927000.0 recorded in Q2 2025.
  • Aquestive Therapeutics' 5-year Change in Inventory high stood at $1.7 million for Q3 2022, and its period low was -$1.0 million during Q2 2023.
  • Its 5-year average for Change in Inventory is $285473.7, with a median of $338000.0 in 2021.
  • Its Change in Inventory has fluctuated over the past 5 years, first skyrocketed by 705416.67% in 2022, then crashed by 53818.18% in 2025.
  • Aquestive Therapeutics' Change in Inventory (Quarter) stood at $1.2 million in 2021, then tumbled by 180.34% to -$944000.0 in 2022, then soared by 67.16% to -$310000.0 in 2023, then crashed by 215.16% to -$977000.0 in 2024, then surged by 75.33% to -$241000.0 in 2025.
  • Its Change in Inventory was -$241000.0 in Q3 2025, compared to $927000.0 in Q2 2025 and $1.2 million in Q1 2025.